
Schroders Capital
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Schroders Capital helps the clients with the management of the investments.
Investor Profile
Schroders Capital has made 26 investments, with 8 in the past 12 months and 23% as lead.
Stage Focus
- Series C (23%)
- Debt Financing (15%)
- Series A (15%)
- Series B (15%)
- Series Unknown (12%)
- Series D (4%)
- Series E (4%)
- Seed (4%)
- Post Ipo Equity (4%)
- Post Ipo Debt (4%)
Country Focus
- United States (27%)
- United Kingdom (27%)
- Switzerland (19%)
- The Netherlands (12%)
- France (4%)
- India (4%)
- Canada (4%)
- Luxembourg (4%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Artificial Intelligence (Ai)
- Renewable Energy
- Pharmaceutical
- Elder Care
- Home Health Care
- Mobile Apps
- Outpatient Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.